|
1
|
Reddy PH and Bal MF: Amyloid beta,
mitochondrial dysfunction and synaptic damage: Implications for
cognitive decline in aging and Alzheimer's disease. Trends Mol Med.
14:45–53. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
LaFerla FM, Green KN and Oddo S:
Intracellular amyloid-beta in Alzheimer's disease. Nat Rev
Neurosci. 8:499–509. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Selkoe DJ: Alzheimer's disease: Genes,
proteins, and therapy. Physiol Rev. 81:741–766. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maher P and Davis JB: The role of
monoamine metabolism in oxidative glutamate toxicity. J Neurosci.
16:6394–6401. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tan S, Wood M and Maher P: Oxidative
stress induces a form of programmed cell death with characteristics
of both apoptosis and necrosis in neuronal cells. J Neurochem.
71:95–105. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tan S, Schubert D and Maher P: Oxytosis: A
novel form of programmed cell death. Curr Top Med Chem. 1:497–506.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stanciu M, Wang Y, Kentor R, Burke N,
Watkins S, Kress G, Reynolds I, Klann E, Angiolieri MR, Johnson JW
and DeFranco DB: Persistent activation of ERK contributes to
glutamate-induced oxidative toxicity in a neuronal cell line and
primary cortical neuron cultures. J Biol Chem. 275:12200–12206.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Choi BH, Hur EM, Lee JH, Jun DJ and Kim
KT: Protein kinase Cdelta-mediated proteasomal degradation of MAP
kinase phosphatase-1 contributes to glutamate-induced neuronal cell
death. J Cell Sci. 119:1329–1340. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Suh HW, Kang S and Kwon KS: Curcumin
attenuates glutamate-induced HT22 cell death by suppressing MAP
kinase signaling. Mol Cell Biochem. 298:187–194. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y and Bhavnani BR: Glutamate-induced
apoptosis in neuronal cells is mediated via caspase-dependent and
independent mechanisms involving calpain and caspase-3 proteases as
well as apoptosis inducing factor (AIF) and this process is
inhibited by equine estrogens. BMC Neurosci. 7:492006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fukui M, Song JH, Choi J, Choi HJ and Zhu
BT: Mechanism of glutamate-induced neurotoxicity in HT22 mouse
hippocampal cells. Eur J Pharmacol. 617:1–11. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fukui M and Zhu BT: Mitochondrial
superoxide dismutase SOD2, but not cytosolic SOD1, plays a critical
role in protection against glutamate-induced oxidative stress and
cell death in HT22 neuronal cells. Free Radic Biol Med. 48:821–830.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rhee SG, Kang SW, Jeong W, Chang TS, Yang
KS and Woo HA: Intracellular messenger function of hydrogen
peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol.
17:183–189. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Budanov AV, Sablina AA, Feinstein E,
Koonin EV and Chumakov PM: Regeneration of peroxiredoxins by
p53-regulated sestrins, homologs of bacterial AhpD. Science.
304:596–600. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kwon J, Lee SR, Yang KS, Ahn Y, Kim YJ,
Stadtman ER and Rhee SG: Reversible oxidation and inactivation of
the tumor suppressor PTEN in cells stimulated with peptide growth
factors. Proc Natl Acad Sci USA. 101:16419–16424. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Evrard C, Capron A, Marchand C, Clippe A,
Wattiez R, Soumillion P, Knoops B and Declercq JP: Crystal
structure of a dimeric oxidized form of human peroxiredoxin 5. J
Mol Biol. 337:1079–1090. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Knoops B, Clippe A, Bogard C, Arsalane K,
Wattiez R, Hermans C, Duconseille E, Falmagne P and Bernard A:
Cloning and characterization of AOEB166, a novel mammalian
antioxidant enzyme of the peroxiredoxin family. J Biol Chem.
274:30451–30458. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Seo MS, Kang SW, Kim K, Baines IC, Lee TH
and Rhee SG: Identification of a new type of mammalian
peroxiredoxin that forms an intramolecular disulfide as a reaction
intermediate. J Biol Chem. 275:20346–20354. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kropotov A, Gogvadze V, Shupliakov O,
Tomilin N, Serikov VB, Tomilin NV and Zhivotovsky B: Peroxiredoxin
V is essential for protection against apoptosis in human lung
carcinoma cells. Exp Cell Res. 312:2806–2815. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun HN, Kim SU, Huang SM, Kim JM, Park YH,
Kim SH, Yang HY, Chung KJ, Lee TH, Choi HS, et al: Microglial
peroxiredoxin V acts as an inducible anti-inflammatory antioxidant
through cooperation with redox signaling cascades. J Neurochem.
114:39–50. 2010.PubMed/NCBI
|
|
21
|
Plaisant F, Clippe A, Vander Stricht D,
Knoops B and Gressens P: Recombinant peroxiredoxin 5 protects
against excitotoxic brain lesions in newborn mice. Free Radic Biol
Med. 34:862–872. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou Y, Kok KH, Chun AC, Wong CM, Wu HW,
Lin MC, Fung PC, Kung H and Jin DY: Mouse peroxiredoxin V is a
thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem
Biophys Res Commun. 268:921–927. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Walbrecq G, Wang B, Becker S, Hannotiau A,
Fransen M and Knoops B: Antioxidant cytoprotection by peroxisomal
peroxiredoxin-5. Free Radic Biol Med. 84:215–226. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma Y, Li R, Zhang Y, Zhou L and Dai Y:
Knockdown of peroxiredoxin 5 inhibits the growth of osteoarthritic
chondrocytes via upregulating Wnt/β-catenin signaling. Free Radic
Biol Med. 76:251–260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
De Simoni S, Linard D, Hermans E, Knoops B
and Goemaere J: Mitochondrial peroxiredoxin-5 as potential
modulator of mitochondria-ER crosstalk in MPP+-induced cell death.
J Neurochem. 125:473–485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu JL, Vallat JM, Pollard JD, Knoops B and
Ouvrier R: Expression of the antioxidant enzyme peroxiredoxin 5 in
the human peripheral nervous system. J Peripher Nerv Syst.
11:318–324. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu J, Luo JH, Pang J, Cao JZ, Wu RH, Tong
ZT, Chen W and Xie D: Lentivirus-mediated RNA interference of
clusterin enhances the chemosensitivity of EJ bladder cancer cells
to epirubicin in vitro. Mol Med Rep. 6:1133–1139. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kang TH, Bae KH, Yu MJ, Kim WK, Hwang HR,
Jung H, Lee PY, Kang S, Yoon TS, Park SG, et al: Phosphoproteomic
analysis of neuronal cell death by glutamate-induced oxidative
stress. Proteomics. 7:2624–2635. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boulos S, Meloni BP, Arthur PG, Bojarski C
and Knuckey NW: Peroxiredoxin 2 overexpression protects cortical
neuronal cultures from ischemic and oxidative injury but not
glutamate excitotoxicity, whereas Cu/Zn superoxide dismutase 1
overexpression protects only against oxidative injury. J Neurosci
Res. 85:3089–3097. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fatma N, Kubo E, Sen M, Agarwal N,
Thoreson WB, Camras CB and Singh DP: Peroxiredoxin 6 delivery
attenuates TNF-alpha- and glutamate-induced retinal ganglion cell
death by limiting ROS levels and maintaining Ca2+ homeostasis.
Brain Res. 1233:63–78. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Murphy TH, Miyamoto M, Sastre A, Schnaar
RL and Coyle JT: Glutamate toxicity in a neuronal cell line
involves inhibition of cystine transport leading to oxidative
stress. Neuron. 2:1547–1558. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jin MH, Lee YH, Kim JM, Sun HN, Moon EY,
Shong MH, Kim SU, Lee SH, Lee TH, Yu DY and Lee DS:
Characterization of neural cell types expressing peroxiredoxins in
mouse brain. Neurosci Lett. 381:252–257. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ishii T, Itoh K, Takahashi S, Sato H,
Yanagawa T, Katoh Y, Bannai S and Yamamoto M: Transcription factor
Nrf2 coordinately regulates a group of oxidative stress-inducible
genes in macrophages. J Biol Chem. 275:16023–16029. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chowdhury I, Mo Y, Gao L, Kazi A, Fisher
AB and Feinstein SI: Oxidant stress stimulates expression of the
human peroxiredoxin 6 gene by a transcriptional mechanism involving
an antioxidant response element. Free Radic Biol Med. 46:146–153.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou Y, Liang Y, Wei J, Chen J and Tang Q:
Lentiviral-mediated p38 MAPK RNAi attenuates aldosterone-induced
myocyte apoptosis. Mol Med Rep. 8:493–498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao WX, Tang SS, Jin X, Zhang CM, Zhang
T, Wang CC, Sun Y and Xiao XL: Olaquindox-induced apoptosis is
suppressed through p38 MAPK and ROS-mediated JNK pathways in HepG2
cells. Cell Biol Toxicol. 29:229–238. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim B, Park J, Chang KT and Lee DS:
Peroxiredoxin 5 prevents amyloid-beta oligomer-induced neuronal
cell death by inhibiting ERK-Drp1-mediated mitochondrial
fragmentation. Free Radic Biol Med. 90:184–194. 2016. View Article : Google Scholar : PubMed/NCBI
|
